Login to Your Account



NewCo News: Ligon Turns Microarray Screening Upside Down

By Catherine Shaffer


Thursday, December 9, 2010
Some potential protein drug targets, such as transcription factors, are difficult to study well in a high-density screening situation. Many transcription factors flop around like wet noodles with little organized structure, and are regarded as "undruggable" by many pharma companies.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription